Roles for NF-κB in nerve cell survival, plasticity, and disease

Cell Death and Differentiation

Volumn 13, Issue 5, 2006, Pages 852-860

  Mattson, M P ^a,b   Meffert, M K ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer; Apoptosis; Hippocampus; Learning and memory; Mitochondria

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYCLOOXYGENASE 2; CYTOKINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MANGANESE SUPEROXIDE DISMUTASE; NERVE GROWTH FACTOR; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; NEUROTROPHIN; PRESENILIN 1; PRESENILIN 2; PROTEIN BCL 2; PROTEIN P50; SYNAPTOTAGMIN; TENASCIN; TRANSCRIPTION FACTOR REL; VASCULOTROPIN; GROWTH PROMOTOR;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; BRAIN CANCER; BRAIN INJURY; CARCINOGENESIS; CELL FUNCTION; CELL STRUCTURE; CELL SURVIVAL; COGNITION; ELECTRIC ACTIVITY; EPILEPSY; GENE ACTIVATION; GENE ACTIVITY; GENE MUTATION; GENE TARGETING; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUNTINGTON CHOREA; MOLECULAR MECHANICS; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; STROKE; BIOLOGICAL MODEL; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; METABOLISM; PATHOLOGY;

ANIMALIA; INTRACISTERNAL A-PARTICLES;

CELL SURVIVAL; DISEASE PROGRESSION; GROWTH SUBSTANCES; HUMANS; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; NEURONS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 33646010041     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401837     Document Type: Review

References (98)

1. Baeuerle PA and Baltimore D (1996) NF-kappa B: Ten years after. Cell 87: 13-20
2. Kaltschmidt B and Kaltschmidt C (1994) Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14: 3981-3992
3. Guerrini L, Blasi F and Denis-Donini S (1995) Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. USA 92: 9077-9081
4. Simpson CS and Morris BJ (1999) Activation of nuclear factor kappaB by nitric oxide in rat striatal neurones: Differential inhibition of the p50 and p65 subunits by dexamethasone. J. Neurochem. 73: 353-361
5. Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS and Mattson MP (1999) Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J. Neurosci. 19: 8856-8865
6. Mao X, Moerman AM and Barger SW (2002) Neuronal kappa B-binding factors consist of Sp1-related proteins. Functional implications for autoregulation of N-methyl-D-aspartate receptor-1 expression. J. Biol. Chem. 277: 44911-44919
7. Levenson JM, Choi S, Lee S-Y, Cao YA, Ahn HJ, Worley KC, Pizzi M, Liou H-C and Sweatt JD (2004) A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. J. Neurosci. 24: 3933-3943
8. May MJ and Ghosh S (1999) IkappaB kinases: Kinsmen with different crafts. Science 284: 271-273
9. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92: 9328-9332
10. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA and Barde YA (1996) Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272: 542-545
11. Maggirwar SB, Sarmiere PD, Dewhurst S and Freeman RS (1998) Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J. Neurosci. 18: 10356-10365
12. Glazner GW, Camandola S and Mattson MP (2000) Nuclear factor-kappaB mediates the cell survival-promoting action of activity-dependent neurotrophic factor peptide-9. J. Neurochem. 75: 101-108
13. Barger SW and Mattson MP (1996) Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Brain Res. Mol. Brain Res. 40: 116-126
14. Krushel LA, Cunningham BA, Edelman GM and Crossin KL (1999) NF-kappaB activity is induced by neural cell adhesion molecule binding to neurons and astrocytes. J. Biol. Chem. 274: 2432-2439
15. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS and Baltimore D (2003) NF-kappa B functions in synaptic signaling and behavior. Nat. Neurosci. 6: 1072-1078
16. Lilienbaum A and Israel A (2003) From calcium to NF-kappa B signaling pathways in neurons. Mol. Cell. Biol. 23: 2680-2698
17. Rojo AI, Salinas M, Martin D, Perona R and Cuadrado A (2004) Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J. Neurosci. 24: 7324-7334
18. Wooten MW (1999) Function for NF-kB in neuronal survival: Regulation by atypical protein kinase C. J. Neurosci. Res. 58: 607-611
19. Kaltschmidt C, Kaltschmidt B and Baeuerle PA (1995) Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc. Natl. Acad. Sci. USA 92: 9618-9622
20. Hoffmann A, Leung TH and Baltimore D (2003) Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J. 22: 5530-5539
21. Gerondakis S, Grossmann M, Nakamura Y, Pohl T and Grumont R (1999) Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: Transgenics and knockouts. Oncogene 18: 6888-6895
22. Leung TH, Hoffmann A and Baltimore D (2004) One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 118: 453-464
23. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC and Karin M (2004) Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J. 23: 4202-4210
24. Sanjabi S, Williams KJ, Saccani S, Zhou L, Hoffman A, Ghosh G, Gerondakis S, Natoli G and Smale ST (2005) A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation. Genes Dev. 19: 2138-2151
25. Meffert MK and Baltimore D (2005) Physiological functions for brain NF-kappaB. Trends Neurosci. 28: 37-43
26. Kaltschmidt B, Widera D and Kaltschmidt C (2005) Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta 1745: 287-299
27. Kassed CA, Willing AE, Garbuzova-Davis S, Sanberg PR and Pennypacker KR (2002) Lack of NF-kappaB p50 exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning. Exp. Neurol. 176: 277-288
28. Kassed CA and Herkenham M (2004) NF-kappaB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxiety. Behav. Brain Res. 154: 577-584
29. Lukiw WJ and Bazan NG (1998) Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J. Neurosci. Res. 53: 583-592
30. Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866
31. Foehr ED, Lin X, O'Mahony A, Geleziunas R, Bradshaw RA and Greene WC (2000) NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J. Neurosci. 20: 7556-7563
32. Karin M and Lin A (2002) NF-kappaB at the crossroads of life and death. Nat. Immunol. 3: 221-227
33. Khursigara G, Orlinick JR and Chao MV (1999) Association of the p75 neurotrophin receptor with TRAF6. J. Biol. Chem. 274: 2597-2600
34. Yeiser EC, Rutkoski NJ, Naito A, Inoue J and Carter BD (2004) Neurotrophin signaling through the p75 receptor is deficient in traf6-/- mice. J. Neurosci. 24: 10521-10529
35. Khursigara G, Bertin J, Yano H, Moffett H, DiStefano PS and Chao MV (2001) A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J. Neurosci. 21: 5854-5863
36. Mamidipudi V, Li X and Wooten MW (2002) Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-kappa B. J. Biol. Chem. 277: 28010-28018
37. Duran A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP, Moscat J and Diaz-Meco MT (2004) The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell 6: 303-309
38. Sanz L, Diaz-Meco MT, Nakano H and Moscat J (2000) The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J. 19: 1576-1586
39. Wooten MW, Seibenhener ML, Mamidipudi V, Diaz-Meco MT, Barker PA and Moscat J (2001) The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor. J. Biol. Chem. 276: 7709-7712
40. Guo Z, Iyun T, Fu W, Zhang P and Mattson MP (2004) Bone marrow transplantation reveals roles for brain macrophage/microglia TNF signaling and nitric oxide production in excitotoxic neuronal death. Neuromolecular Med. 5: 219-234
41. Gabriel C, Justicia C, Camins A and Planas AM (1999) Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia. Brain Res. Mol. Brain Res. 65: 61-69
42. Sestan N, Artavanis-Tsakonas S and Rakic P (1999) Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. Science 286: 741-746
43. Salama-Cohen P, Arevalo MA, Meier J, Grantyn R and Rodriguez-Tebar A (2005) NGF controls dendrite development in hippocampal neurons by binding to p75NTR and modulating the cellular targets of Notch. Mol. Biol. Cell 16: 339-347
44. Torgerson TR, Colosia AD, Donahue JP, Lin YZ and Hawiger J (1998) Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50. J. Immunol. 161: 6084-6092
45. Kolenko V, Bloom T, Rayman P, Bukowski R, His E and Finke J (1999) Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J. Immunol. 163: 590-598
46. Boothby M (2001) Specificity of sn50 for NF-kappa B? Nat. Immunol. 2: 471-472
47. Wang J, Shelly L, Miele L, Boykins R, Norcross MA and Guan E (2001) Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain. J. Immunol. 167: 289-295
48. Lin A and Karin M (2003) NF-kappaB in cancer: A marked target. Semin. Cancer Biol. 13: 107-114
49. Aggarwal BB (2004) Nuclear factor-kappaB: The enemy within. Cancer Cell 6: 203-208
50. Greten FR and Karin M (2004) The IKK/NF-kappaB activation pathway - a target for prevention and treatment of cancer. Cancer Lett. 206: 193-199
51. Barkett M and Gilmore TD (1999) Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18: 6910-6924
52. Gilmore T, Gapuzan ME, Kalaitzidis D and Starczynowski D (2002) Rel/ NF-kappa B/I kappa B signal transduction in the generation and treatment of human cancer. Cancer Lett. 181: 1-9
53. Tacconelli A, Farina AR, Cappabianca L, Desantis G, Tessitore A, Vetuschi A, Sferra R, Rucci N, Argenti B, Screpanti I, Gulino A and Mackay AR (2004) TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6: 347-360
54. Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, Barnett GH and Jain RK (2004) The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428: 328-332
55. Wang H, Wang H, Zhang W, Huang HJ, Liao WS and Fuller GN (2004) Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab. Invest. 84: 941-951
56. Robe PA, Bentires-Alj M, Bonif M, Rogister B, Deprez M, Haddada H, Khac MT, Jolois O, Erkmen K, Merville MP, Black PM and Bours V (2004) In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin. Cancer Res. 10: 5595-5603
57. Mattson MP, Goodman Y, Luo H, Fu W and Furukawa K (1997) Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49: 681-697
58. Cheng B, Christakos S and Mattson MP (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12: 139-153
59. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, Mizuno T and Tohyama M (1999) Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274: 8531-8538
60. Marchetti L, Klein M, Schlett K, Pfizenmaier K and Eisel UL (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J. Biol. Chem. 279: 32869-32881
61. Zhu Y, Culmsee C, Klumpp S and Kriegelstein J (2004) Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience 123: 897-906
62. Kovacs AD, Chakraborty-Sett S, Ramirez SH, Sniderhan LF, Williamson AL and Maggirwar SB (2004) Mechanism of NF-kappaB inactivation induced by survival signal withdrawal in cerebellar granule neurons. Eur. J. Neurosci. 20: 345-352
63. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T and Schwaninger M (1999) NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5: 554-559
64. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M and Koistinaho J (2004) Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35: 987-991
65. Clemens JA, Stephenson DT, Smalstig EB, Dixon EP and Little SP (1997) Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke 28: 1073-1080; discussion 1080-1071
66. Grilli M, Pizzi M, Memo M and Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274: 1383-1385
67. Shou Y, Gunaskar PG, Borowitz JL and Isom GE (2000) Cyanide-induced apoptosis involves oxidative-stress-activated NF-kappaB in cortical neurons. Toxicol. Appl. Pharmacol. 164: 196-205
68. John GR, Lee SC and Brosnan CF (2003) Cytokines: Powerful regulators of glial cell activation. Neuroscientist 9: 10-22
69. Akama KT, Albanese C, Pestell RG and Van Eldik LJ (1998) Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc. Natl. Acad. Sci. USA 95: 5795-5800
70. Prasad AV, Pilcher WH and Joseph SA (1994) Nuclear factor-kappa B in rat brain: Enhanced DNA-binding activity following convulsant-induced seizures. Neurosci. Lett. 170: 145-148
71. Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi FM, Pfeiffer J, Kaltschmidt C, Israel A and Memet S (2003) Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J. Neurosci. 23: 9403-9408
72. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD and Yezierski RP (1998) Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18: 3251-3260
73. Sullivan PG, Bruce-Keller AJ, Rabchevsky AG, Christakos S, Clair DK, Mattson MP and Scheff SW (1999) Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J. Neurosci. 19: 6248-6256
74. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA and Kaltschmidt C (1997) Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94: 2642-2647
75. Guo Q, Robinson N and Mattson MP (1998) Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kappaB and stabilization of calcium homeostasis. J. Biol. Chem. 273: 12341-12351
76. Boissiere F, Hunot S, Faucheux B, Duyckaerts C, Hauw JJ, Agid Y and Hirsch EC (1997) Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease. NeuroReport 8: 2849-2852
77. Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM and Mattson MP (1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat. Med. 4: 957-962
78. Camandola S and Mattson MP (2000) Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression. J. Neurosci. Res. 61: 134-139
79. Ho GJ, Drego R, Hakimian E and Masliah E (2005) Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr. Drug Targets Inflamm. Allergy 4: 247-256
80. Grilli M, Goffi F, Memo M and Spano P (1996) Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J. Biol. Chem. 271: 15002-15007
81. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430: 631-639
82. Kassed CA, Butler TL, Navidomskis MT, Gordon MN, Morgan D and Pennypacker KR (2003) Mice expressing human mutant presenilin-1 exhibit decreased activation of NF-kappaB p50 in hippocampal neurons after injury. Brain Res. Mol. Brain Res. 110: 152-157
83. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y and Hirsch EC (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. USA 94: 7531-7536
84. Jenner P and Olanow CW (1998) Understanding cell death in Parkinson's disease. Ann. Neurol. 44: S72-S84
85. Park SH, Choi WS, Yoon SY, Ahn YS and Oh YJ (2004) Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+-induced dopaminergic neuronal cell death: Its potential role as a survival determinant. Biochem. Biophys. Res. Commun. 322: 727-733
86. Yu Z, Zhou D, Cheng G and Mattson MP (2000) Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease. J. Mol. Neurosci. 15: 31-44
87. Khoshnan A, Ko J, Watkin EE, Paige LA, Reinhart PH and Patterson PH (2004) Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity. J. Neurosci. 24: 7999-8008
88. Gill JS and Windebank AJ (2000) Ceramide initiates NFkappaB-mediated caspase activation in neuronal apoptosis. Neurobiol. Dis. 7: 448-461
89. Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ, Sekiguchi JM, Rathbun GA, Swat W, Wang J, Bronson RT, Malynn BA, Bryans M, Zhu C, Chaudhuri J, Davidson L, Ferrini R, Stamato T, Orkin SH, Greenberg ME and Alt FW (1998) A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95: 891-902
90. Gilmore EC, Nowakowski RS, Caviness Jr VS and Herrup K (2000) Cell birth, cell death, cell diversity and DNA breaks: How do they all fit together? Trends Neurosci. 23: 100-105
91. Uberti D, Ferrari Toninelli G and Memo M (2003) Involvement of DNA damage and repair systems in neurodegenerative process. Toxicol. Lett. 139: 99-105
92. Huang TT, Wuerzberger-Davis SM, Wu ZH and Miyamoto S (2003) Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115: 565-576
93. Hur GM, Lewis J, Yang Q, Lin Y, Nakano H, Nedospasov S and Liu ZG (2003) The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev. 17: 873-882
94. Bohuslav J, Chen LF, Kwon H, Mu Y and Greene WC (2004) p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279: 26115-26125
95. Aleyasin H, Cregan SP, Iyirhiaro G, O'Hare MJ, Callaghan SM, Slack RS and Park DS (2004) Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. J. Neurosci. 24: 2963-2973
96. Culmsee C, Siewe J, Junker V, Retiounskaia M, Schwarz S, Camandola S, El-Metainy S, Behnke H, Mattson MP and Kriegelstein J (2003) Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J. Neurosci. 23: 8586-8595
97. Marini AM, Jiang X, Wu W, Tain F, Zhu D, Okagaki P and Lipsky RH (2004) Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: From genes to phenotype. Restor. Neurol. Neurosci. 22: 121-130
98. Mattson MP, Maudsley S and Martin B (2004) BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 27: 589-594